22 results match your criteria: "and Autoimmunity Center[Affiliation]"

Peripheral blood mononuclear cells (PBMCs) are commonly used in biomedical research on the immune system and its response to disease and pathogens. This detailed protocol describes the equipment, supplies, and steps for isolating, cryopreserving, and thawing high-quality and highly viable PBMCs from whole blood cells suitable for downstream applications such as flow cytometry and RNA-sequencing. Protocols for processing plasma and buffy coat from the whole blood in parallel and concurrently with PBMCs are also described.

View Article and Find Full Text PDF

Myositis India: Early lessons from a patient support group in a resource-limited setting.

Int J Rheum Dis

September 2024

Division of Rheumatology and Clinical Immunology, Arthritis and Autoimmunity Center and UPMC Myositis Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

View Article and Find Full Text PDF

Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping review.

Rheumatol Int

November 2024

Department of Medicine, Arthritis and Autoimmunity Center and UPMC Myositis Center, Division of Rheumatology and Clinical Immunology, School of Medicine, University of Pittsburgh, BST S 727, 3500 Terrace Street, Pittsburgh, PA, 15261, USA.

Anti-synthetase syndrome constitutes a dynamically evolving subset of Idiopathic Inflammatory Myopathy, however, the nomenclature and abbreviations for this syndrome are plagued by heterogeneity, leading to lack of consistency in literature. The objective of this study is to evaluate existing diversity in disease names and abbreviations, with a future goal to develop consensus on the nomenclature. A scoping review format was used for analysis.

View Article and Find Full Text PDF

Internet-based enrollment of a myositis patient cohort-a national experience.

Clin Rheumatol

October 2024

Division of Rheumatology and Clinical Immunology, Arthritis and Autoimmunity Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Introduction: Recruitment for idiopathic inflammatory myopathies (IIM) research is a challenge due to the rarity of the disease and the scarcity of specialized myositis centers. Online recruitment may be a feasible alternative to reach rare disease patients. We evaluated various online recruitment methods in a large longitudinal IIM cohort.

View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICIs) have demonstrated efficacy and improved survival in a growing number of cancers. Despite their success, ICIs are associated with immune-related adverse events that can interfere with their use. Therefore, safer approaches are needed.

View Article and Find Full Text PDF

Background And Contribution: In network biology, molecular functions can be characterized by network-based inference, or "guilt-by-associations." PageRank-like tools have been applied in the study of biomolecular interaction networks to obtain further the relative significance of all molecules in the network. However, there is a great deal of inherent noise in widely accessible data sets for gene-to-gene associations or protein-protein interactions.

View Article and Find Full Text PDF

The ability of individuals with end-stage osteoarthritis (OA) to functionally recover from total joint arthroplasty is highly inconsistent. The molecular mechanisms driving this heterogeneity have yet to be elucidated. Furthermore, OA disproportionately impacts females, suggesting a need for identifying female-specific therapeutic targets.

View Article and Find Full Text PDF

Many individuals with end-stage osteoarthritis (OA) undergo elective total hip/knee arthroplasty (THA/TKA) to relieve pain, improve mobility and quality of life. However, ∼30% suffer long-term mobility impairment following surgery. This may be in part due to muscle inflammation susceptibility (MuIS+), an overt proinflammatory pathology localized to skeletal muscle surrounding the diseased joint, present in some patients with TKA/THA.

View Article and Find Full Text PDF

COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.

Rheumatol Int

January 2022

Division of Rheumatology and Clinical Immunology, Department of Medicine, UPMC Arthritis and Autoimmunity Center, School of Medicine, University of Pittsburgh, 3601 Fifth Ave., Suite 2B, Pittsburgh, PA, 15213, USA.

The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection.

View Article and Find Full Text PDF

Objective: The purpose of the study was to synthesize studies of movement patterns and their association with hip pain, function/activity, and morphology in individuals with femoroacetabular impingement syndrome (FAIS).

Methods: PubMed, SPORTDiscus, CINAHL, Embase, and Scopus databases were searched using predefined terms. Two authors independently reviewed abstracts and full texts.

View Article and Find Full Text PDF

Antisynthetase syndrome: A distinct disease spectrum.

J Scleroderma Relat Disord

October 2020

Arthritis and Autoimmunity Center and UPMC Myositis Center, Division of Rheumatology and Clinical Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

The discovery of novel autoantibodies related to idiopathic inflammatory myopathies (collectively referred to as myositis) has not only advanced our understanding of the clinical, serological, and pathological correlation in the disease spectrum but also played a role in guiding management and prognosis. One group of the myositis-specific autoantibodies is anti-aminoacyl-tRNA synthetase (anti-ARS or anti-synthetase) which defines a syndrome with predominant interstitial lung disease, arthritis, and myositis. Autoantibodies to eight aminoacyl-tRNA synthetases have been identified with anti-Jo1 the most common in all of idiopathic inflammatory myopathies.

View Article and Find Full Text PDF

Inclusion body myositis is a rare sporadic inflammatory-degenerative myopathy of the elderly. Despite being the commonest type of acquired myopathy after the age of 50, misdiagnosis is extremely common. The most frequent hurdle in identifying new cases is the wrong diagnosis of polymyositis or motor neuron disease.

View Article and Find Full Text PDF

Risk Factors and Cancer Screening in Myositis.

Rheum Dis Clin North Am

August 2020

Myositis Center, Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, 3601 5th Avenue, Suite 2B, Pittsburgh, PA 15261, USA; UPMC Arthritis and Autoimmunity Center, Falk Medical Building, 3601 Fifth Avenue, Suite 2B, Pittsburgh, PA 15213, USA. Electronic address:

The idiopathic inflammatory myopathies, particularly dermatomyositis, are associated with an increased risk of cancer. Lung, ovarian, breast, colon, prostate, and cervical cancers, and hematologic malignancies, are among the most common associated cancers. Risk stratification for cancer in patients with myositis is based on clinical risk factors/red flags, myositis clinical subtypes, and myositis-specific autoantibodies.

View Article and Find Full Text PDF

The Scleroderma Clinical Trials Consortium (SCTC) represents many of the clinical researchers in the world who are interested in improving the efficiency of clinical trials in Systemic Sclerosis (SSc). The SCTC has established 11 working groups (WGs) to develop and validate better ways of measuring and recording multiple aspects of this heterogeneous disease. These include groups working on arthritis, disease damage, disease activity, cardiac disease, juvenile SSc, the gastrointestinal tract, vascular component, calcinosis, scleroderma renal crisis, interstitial lung disease, and skin measurement.

View Article and Find Full Text PDF

Drs. Aggarwal and Oddis reply.

J Rheumatol

March 2018

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

View Article and Find Full Text PDF

Genomics in Rheumatic Diseases: Hope for the Future.

Rheum Dis Clin North Am

August 2017

Public Health Genomics and Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. Electronic address:

View Article and Find Full Text PDF

Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases.

Diseases

December 2016

Department of Biochemistry and Molecular Genetics, Gregory Fleming Cystic Fibrosis Research Center, Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA; ; Tel.: +1-205-975-6585.

In-frame premature termination codons (PTCs) (also referred to as nonsense mutations) comprise ~10% of all disease-associated gene lesions. PTCs reduce gene expression in two ways. First, PTCs prematurely terminate translation of an mRNA, leading to the production of a truncated polypeptide that often lacks normal function and/or is unstable.

View Article and Find Full Text PDF

Exercise Medicine for Osteoarthritis: Research Strategies to Maximize Effectiveness.

Arthritis Care Res (Hoboken)

March 2016

University of Alabama at Birmingham Center for Exercise Medicine, BioMatrix Engineering and Regenerative Medicine Center, and Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center, Birmingham.

View Article and Find Full Text PDF

Muscle inflammation susceptibility: a prognostic index of recovery potential after hip arthroplasty?

Am J Physiol Endocrinol Metab

April 2015

Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Univeristy of Alabama at Birmingham Center for Exercise Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center, University of Alabama at Birmingham, Birmingham, Alabama; Medicine Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and Research Collaborator, Mayo Clinic College of Medicine, Rochester, Minnesota.

While elective total hip arthroplasty (THA) for end-stage osteoarthritis (OA) improves pain, mobility function, and quality of life in most cases, a large proportion of patients suffer persistent muscle atrophy, pain, and mobility impairment. Extensive skeletal muscle damage is unavoidable in these surgical procedures, and it stands to reason that poor recovery and long-term mobility impairment among some individuals after THA is linked to failed muscle regeneration and regrowth following surgery and that local muscle inflammation susceptibility (MuIS) is a major contributing factor. Here we present results of two integrated studies.

View Article and Find Full Text PDF

Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.

J Allergy Clin Immunol

February 2015

Department of Microbiology, University of Alabama at Birmingham, Birmingham, Ala; Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Ala; Comprehensive Arthritis, Musculoskeletal and Autoimmunity Center, University of Alabama at Birmingham, Birmingham, Ala. Electronic address:

Background: Subsets of myeloid-derived regulatory cells (MDRCs), which are phenotypically similar to the myeloid-derived suppressor cells found in patients with cancer, have recently been appreciated as critical regulators of airway inflammation in mouse models of asthma.

Objective: We test the hypothesis that subsets of airway MDRCs contribute differentially to the inflammatory milieu in human asthma and chronic obstructive pulmonary disease (COPD).

Methods: We used bronchoalveolar lavage to identify and characterize human airway MDRCs from 10 healthy subjects, 9 patients with mild asthma, and 8 patients with COPD, none of whom were treated with inhaled or systemic corticosteroids.

View Article and Find Full Text PDF

ANCA-associated small vessel vasculitis: clinical and therapeutic advances.

Curr Rheumatol Rep

December 2010

University of Pittsburgh, Arthritis and Autoimmunity Center, Pittsburgh, PA 15213, USA.

The antineutrophil cytoplasmic antibodies-associated small vessel vasculitides are an encompassing group of diseases defined by serologic and anatomic criteria. Their diverse phenotype is an ongoing diagnostic challenge, and early diagnosis is paramount in optimizing outcomes and minimizing morbidity. Therapies targeted at components of the immune system, both cellular and cytokine, have been assessed as both inducers and sustainers of remission.

View Article and Find Full Text PDF

Pathways: Strategies for susceptibility genes in SLE.

Autoimmun Rev

May 2010

Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center, Department of Medicine, University of Alabama at Birmingham, USA.

Systemic lupus erythematosus (SLE) is a complex autoimmune disorder marked by an inappropriate immune response to nuclear antigens. Recent whole genome association and more focused studies have revealed numerous genes implicated in this disease process, including ITGAM, Fc gamma receptors, complement components, C-reactive protein, and others. One common feature of these molecules is their involvement in the immune opsonin pathway and in phagocytic clearing of nuclear antigens and apoptotic debris, which provide excessive exposure of lupus-related antigens to immune cells.

View Article and Find Full Text PDF